Volume 22, Number 9—September 2016
Research
Ebola Virus Disease, Democratic Republic of the Congo, 2014
Table 3
Symptom, sign | Survived, no. (%) | Died, no. (%) | Total, no. (%) | Average no. days | CFR | Relative risk (95% CI) | p value | Patient age group, y, % |
p value | |
---|---|---|---|---|---|---|---|---|---|---|
<15 | >15 | |||||||||
Symptom | ||||||||||
Asthenia | 12 (92.3) | 12 (100) | 24 (96.0) | 4 | 50.0 | 0 | 88.9 | 100.0 | 0.36 | |
Anorexia | 7 (53.8) | 10 (83.3) | 17 (68.0) | 2.9 | 58.8 | 2.35 (0.66–8.33) | 0.2 | 44.4 | 81.3 | 0.075 |
Myalgia | 6 (46.1) | 9 (75.0) | 15 (60.0) | 2.3 | 60.0 | 2 (0.71–5.62) | 0.22 | 11.1 | 87.5 | 0 |
Arthralgia | 5 (38.4) | 6 (50.0) | 11 (44.0) | 2.4 | 54.5 | 1.27 (0.56–2.86) | 0.69 | 11.1 | 62.5 | 0.017 |
Headache | 6 (46.1) | 5 (41.7) | 11 (44.0) | 2 | 45.5 | 0.90 (0.39–2.09) | 10 | 22.2 | 56.3 | 0.11 |
RUQ abdominal pain | 3 (23.1) | 7 (58.3) | 10 (40.0) | 2.3 | 70.0 | 2.10 (0.92–4.78) | 0.11 | 11.1 | 56.3 | 0.034 |
Difficulty swallowing | 2 (15.4) | 6 (50.0) | 8 (32.0) | 1 | 75.0 | 2.12 (0.99–4.53) | 0.09 | 0 | 50.0 | 0.012 |
Nausea | 3 (23.1) | 5 (41.7) | 8 (32.0) | 2.3 | 62.5 | 1.52 (0.69–3.31) | 0.41 | 0 | 50.0 | 0.012 |
Dyspnea | 0 (0) | 6 (50.0) | 6 (24.0) | 100.0 | 3.16 (1.63–6.13) | 0.005 | 11.1 | 31.3 | 0.267 | |
Disorientation | 0 (0) | 6 (50.0) | 6 (24.0) | 100.0 | 3.16 (1.63–6.14) | 0.005 | 11.1 | 31.3 | 0.267 | |
Cough | 1 (7.7) | 2 (16.6) | 3 (12.0) | 1 | 66.7 | 1.46 (0.58–3.69) | 0.59 | 0 | 18.8 | 0.243 |
Chest pain | 1 (7.7) | 2 (16.6) | 3 (12.0) | 1 | 66.7 | 1.46 (0.58–3.69) | 0.59 | 0 | 18.8 | 0.243 |
Back pain | 1 (7.7) | 1 (8.3) | 2 (8.0) | 2 | 50.0 | 1 (0.24–4.45) | 10 | 0 | 12.5 | 0.4 |
Stomach pain/cramps | 2 (15.4) | 0 | 2 (8.0) | 1 | 0 | 0 | 0.0 | 0 | 12.5 | 0.4 |
Diarrhea | 6 (46.1) | 11 (91.7) | 17 (68.0) | 2.3 | 64.7 | 5.17 (0.8–33.5) | 0.03 | 44.4 | 81.3 | 0.075 |
Fever up to 39.5°C | 4 (33.3) | 11 (91.7) | 15 (60.0) | 1.5 | 73.3 | 7.33 (1.11–48.2) | 0.003 | 44.4 | 68.8 | 0.222 |
Vomiting | 7 (53.8) | 8 (66.6) | 15 (60.0) | 1.3 | 53.3 | 1.33 (0.54–3.20) | 0.68 | 100.0 | 100.0 | 0.053 |
Dehydration | 1 (7.7) | 8 (66.6) | 9 (36.0) | 1 | 88.9 | 3.55 (1.47–8.56) | 0.003 | 22.2 | 43.8 | 0.264 |
Hiccups | 0 | 4 (33.3) | 4 (16.0) | 100.0 | 2.62 (1.52–4.53) | 0.04 | 11.1 | 18.8 | 0.54 | |
Tender abdomen | 1 (7.7) | 2 (16.6) | 3 (12.0) | 4 | 66.7 | 1.46 (0.58–3.68) | 0.59 | 0 | 18.8 | 0.243 |
Fever >39.5°C | 1 (7.7) | 1 (8.3) | 2 (8.0) | 1 | 50.0 | 1.04 (0.24–4.45) | 10 | 11.1 | 6.3 | 0.6 |
Nonhemorrhagic rash |
0 |
1 (8.3) |
1 (4.0) |
2 |
100.0 |
2.18 (1.41–3.37) |
0.48 |
0 |
6.3 |
0.64 |
Hemorrhagic sign | ||||||||||
Hemorrhagic | 4 (30.7) | 9 (75.0) | 13 (52.0) | 3.5 | 69.20 | 2.77 (0.97–7.87) | 0.04 | 44.4 | 56.3 | 0.44 |
Hemorrhagic, excluding red eyes/subconjunctival hemorrhage | 2 (15.4) | 9 (75.0) | 11 (44.0) | 1 | 85.70 | 3.81 (1.34–10.8) | 0.03 | 33.3 | 50.0 | 0.3 |
Bloody feces | 1 (7.7) | 6 (50.0) | 7 (28.0) | 1 | 85.7 | 2.57 (1.25–5.28) | 0.03 | 33.3 | 25.0 | 0.499 |
Bleeding from injection site | 1 (7.7) | 5 (41.7) | 6 (24.0) | 1 | 83.3 | 2.26 (1.13–4.50) | 0.07 | 22.2 | 25.0 | 0.637 |
Red eyes/subconjunctival hemorrhage | 3 (23.1) | 3 (25.0) | 6 (24.0) | 4 | 50.0 | 1.05 (0.41–2.67) | 10 | 11.1 | 31.3 | 0.267 |
Hematemesis | 0 | 5 (41.7) | 5 (20.0) | 100.0 | 2.87 (1.57–5.19) | 0.01 | 11.1 | 25.0 | 0.391 | |
Hemoptysis | 0 | 2 (16.6) | 2 (8.0) | 100.0 | 2.30 (1.44–3.66) | 0.22 | 0 | 12.5 | 0.4 | |
Epistaxis | 0 | 1 (8.3) | 1 (4.0) | 100.0 | 2.18 (1.41–3.37) | 0.48 | 0 | 6.3 | 0.64 | |
Gingival/oral bleeding | 0 | 1 (8.3) | 1 (4.0) | 1 | 100.0 | 2.18 (1.41–3.37) | 0.48 | 11.1 | 0 | 0.36 |
*RUQ, right upper quadrant.
Page created: August 16, 2016
Page updated: August 16, 2016
Page reviewed: August 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.